Stephen Moses: Difference between revisions
m using UNI template |
WikiModEn2 (talk | contribs) →Active projects: Wikify. |
||
| (5 intermediate revisions by 2 users not shown) | |||
| Line 80: | Line 80: | ||
|last= | |last= | ||
|first= | |first= | ||
|publisher=Doctors Opposing Circumcision | |publisher=[[Doctors Opposing Circumcision (D.O.C.)]] | ||
|date=2016 | |date=2016 | ||
|title=HIV/AIDS | |title=HIV/AIDS | ||
|url=https://www.doctorsopposingcircumcision.org/for-professionals/alleged-medical-benefits/hivaids/ | |url=https://www.doctorsopposingcircumcision.org/for-professionals/alleged-medical-benefits/hivaids/ | ||
|accessdate=2020-03-23 | |accessdate=2020-03-23 | ||
}}</ref>Of the three {{#tip-text:RCT|Randomized controlled trial}}s being used by the [[WHO]] to endorse circumcision as [[HIV]] prevention, Stephen Moses and [[Robert C. Bailey]] headed the {{#tip-text:RCT|Randomized controlled trial}} that was carried out in Kenya.<ref>Bailey | }}</ref>Of the three {{#tip-text:RCT|Randomized controlled trial}}s being used by the [[WHO]] to endorse circumcision as [[HIV]] prevention, Stephen Moses and [[Robert C. Bailey]] headed the {{#tip-text:RCT|Randomized controlled trial}} that was carried out in Kenya.<ref>{{RCT Bailey et al 2007}}</ref> Moses obviously brought his pre-existing bias in favor of male circumcision into the trial, so he did not start from a neutral position. | ||
Moses' research on circumcision protection from [[HIV]] infection is now completely discredited. Boyle & Hill (2011) reviewed the three randomized controlled trials (RCTs) and found disabling methodological and statistical errors in all three. Although a 60 percent ''relative'' reduction in [[HIV]] was claimed, the ''absolute'' reduction was a statistically insignificant 1.3 percent.<ref name="boyle-hill2011">{{BoyleGJ HillG 2011}}</ref> Garenne & Matthews (2019) report that circumcised men have as much [[HIV]] infection as intact men.<ref>{{REFjournal | Moses' research on circumcision protection from [[HIV]] infection is now completely discredited. Boyle & Hill (2011) reviewed the three randomized controlled trials (RCTs) and found disabling methodological and statistical errors in all three. Although a 60 percent ''relative'' reduction in [[HIV]] was claimed, the ''absolute'' reduction was a statistically insignificant 1.3 percent.<ref name="boyle-hill2011">{{BoyleGJ HillG 2011}}</ref> [[Michel Garenne|Garenne]] & Matthews (2019) report that circumcised men have as much [[HIV]] infection as intact men.<ref>{{REFjournal | ||
|last=Garenne | |last=Garenne | ||
|init=M | |init=M | ||
|author-link= | |author-link=Michel Garenne | ||
|last2=Matthews | |last2=Matthews | ||
|init2=A | |init2=A | ||
| Line 115: | Line 115: | ||
* A randomized, controlled trial of male circumcision to reduce [[HIV]] incidence in Kisumu, Kenya.<ref name='moses-bio'/><br><small>[[National Institutes of Health]].</small> | * A randomized, controlled trial of male circumcision to reduce [[HIV]] incidence in Kisumu, Kenya.<ref name='moses-bio'/><br><small>[[National Institutes of Health]].</small> | ||
* Scaling up [[HIV]] prevention in Karnataka and southern Maharashtra, Phase II.<ref name='moses-bio'/><br><small>[[Bill & Melinda Gates Foundation]].</small> | * Scaling up [[HIV]] prevention in Karnataka and southern Maharashtra, Phase II.<ref name='moses-bio'/><br><small>[[Bill & Melinda Gates Foundation]].</small> | ||
* Monitoring and evaluation of the Avahan project in India.<ref name='moses-bio'/><br><small>[[Bill & Melinda Gates Foundation]].</small> | * Monitoring and evaluation of the Avahan project in [[India]].<ref name='moses-bio'/><br><small>[[Bill & Melinda Gates Foundation]].</small> | ||
* Technical assistance to improve maternal, neonatal & child health through National Rural Health Mission, India.<ref name='moses-bio'/><br><small>[[Bill & Melinda Gates Foundation]].</small> | * Technical assistance to improve maternal, neonatal & child health through National Rural Health Mission, [[India]].<ref name='moses-bio'/><br><small>[[Bill & Melinda Gates Foundation]].</small> | ||
* Mapping key populations for [[HIV]] prevention in Sri Lanka.<ref name='moses-bio'/><br><small>World Bank.</small> | * Mapping key populations for [[HIV]] prevention in Sri Lanka.<ref name='moses-bio'/><br><small>World Bank.</small> | ||
{{PUB}} | |||
* | * {{REFjournal | ||
|last=Smith | |last=Smith | ||
|init=JS | |init=JS | ||
| Line 127: | Line 127: | ||
|last3=Hudgens | |last3=Hudgens | ||
|init3=MG | |init3=MG | ||
|last4=Bailey | |||
|first4=Robert C. | |||
|init4=RC | |||
|author4-link=Robert C. Bailey | |||
|last5=Agot | |||
|init5=K | |||
|last6=Ndinya-Achola | |||
|init6=JO | |||
|last7=Moses | |||
|init7=S | |||
|author7-link=Stephen Moses | |||
|etal=yes | |etal=yes | ||
|date=2010-01 | |date=2010-01 | ||
| Line 139: | Line 150: | ||
|DOI=10.1002/ijc.24770 | |DOI=10.1002/ijc.24770 | ||
|accessdate= | |accessdate= | ||
}} | }} | ||
* | * {{REFjournal | ||
|last=Moses | |last=Moses | ||
|init=S | |init=S | ||
|author-link=Stephen Moses | |author-link=Stephen Moses | ||
|date=2009-10 | |date=2009-10 | ||
|title=Male circumcision: a new approach to reducing HIV transmission | |title=Top Achievements in Health Research: Male circumcision: a new approach to reducing HIV transmission | ||
|journal=CMAJ | |journal=CIHR/CMAJ | ||
|volume=181 | |volume=181 | ||
|issue=8 | |issue=8 | ||
| Line 155: | Line 166: | ||
|DOI=10.1503/cmaj.090809 | |DOI=10.1503/cmaj.090809 | ||
|accessdate= | |accessdate= | ||
}} | }} | ||
* | * {{REFjournal | ||
|last=Mehta | |last=Mehta | ||
|init=SD | |init=SD | ||
|last2=Gray | |last2=Gray | ||
|init2=RH | |init2=RH | ||
|author2-link=Ronald H. Gray | |||
|last3=Auvert | |last3=Auvert | ||
|init3=B | |init3=B | ||
|author3-link=Bertran Auvert | |||
|last4=Moses | |||
|init4=S | |||
|author4-link=Stephen Moses | |||
|last5=Kigozi | |||
|init5=G | |||
|author5-link=Godfrey Kigozi | |||
|last6=Taljaard | |||
|init6=D | |||
|last7=Puren | |||
|init7=A | |||
|last8=Agot | |||
|init8=K | |||
|last9=Serwadda | |||
|init9=D | |||
|other=Parker CB, [[Maria Wawer|Wawer MJ]], [[Robert C. Bailey|Bailey RC]] | |||
|etal=yes | |etal=yes | ||
|date=2007-07 | |date=2007-07 | ||
| Line 176: | Line 204: | ||
|accessdate= | |accessdate= | ||
}} | }} | ||
* {{RCT Bailey et al 2007}} | |||
* | * {{REFjournal | ||
}} | |||
* | |||
|last=Nagelkerke | |last=Nagelkerke | ||
|init= | |init=NJD | ||
|last2=Moses | |last2=Moses | ||
|init2=S | |init2=S | ||
| Line 208: | Line 215: | ||
|last4=Bailey | |last4=Bailey | ||
|init4=RC | |init4=RC | ||
|author4-link=Robert C. Bailey | |||
|date=2007 | |date=2007 | ||
|title=Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa | |title=Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa | ||
| Line 219: | Line 227: | ||
|DOI=10.1186/1471-2334-7-16 | |DOI=10.1186/1471-2334-7-16 | ||
|accessdate= | |accessdate= | ||
}} | }} | ||
* | * {{REFjournal | ||
|last=Krieger | |last=Krieger | ||
|init=JN | |init=JN | ||
|last2=Bailey | |last2=Bailey | ||
|init2=RC | |init2=RC | ||
|last3= | |author2-link=Robert C. Bailey | ||
|init3= | |last3=Agot | ||
|init3=K | |||
|last4=Parker | |||
|init4=C | |||
|last5=Ndinya-Achola | |||
|init5=JO | |||
|last6=Moses | |||
|init6=S | |||
|author6-link=Stephen Moses | |||
|etal=yes | |etal=yes | ||
|date=2007 | |date=2007 | ||
|title=Adult male circumcision outcomes: experience in a developing country setting | |title=Adult male circumcision outcomes: experience in a developing country setting | ||
|journal=Urol | |journal=Urol Int | ||
|volume=78 | |volume=78 | ||
|issue=3 | |issue=3 | ||
| Line 239: | Line 255: | ||
|accessdate= | |accessdate= | ||
}} | }} | ||
{{SEEALSO}} | {{SEEALSO}} | ||
* [[Bias]] | * [[Bias]] | ||
* [[Canada]] | |||
* [[Circumcised doctors]] | * [[Circumcised doctors]] | ||
| Line 253: | Line 269: | ||
[[Category:Researcher]] | [[Category:Researcher]] | ||
[[Category:Author]] | |||
[[Category:Canada]] | [[Category:Canada]] | ||